News

A personality test developed in Lleida and in the United States is capable of measuring personality disorders by unifying the criteria of the World Health Organization and the American Psychiatric Association

IRBLleida raises 136.20 euros for the AECC Lleida thanks to the pilot programme to promote fruit consumption in the workplace

The French Association of Ataxia in Friedreich renews its 25,000 euro grant to validate the therapeutic potential of calcitriol for treating this rare malaltia

The drug SAR405, the best inhibitor of autophagy

Described the function of the EndoG protein, which is key to cell proliferation and the control of oxygen free radicals

New clinical trial improves survival in breast cancer patients with luminal phenotype and high risk of recurrence

84% of patients with COVID-19 who have been admitted to the ICU have respiratory problems at the three-month discharge chief

A study with the participation of researchers from Lleida demonstrates the link between intestinal microbes and recent memory

Ilerdent renews its collaboration with IRBLleida

A personality trait called "Alexythymia" is associated with the risk of having a heart attack

New boost for HIPARCO-score, a personalised medicine tool for resistant hypertension

McDonald's Lleida renews its collaboration with IRBLleida